Archive for the ‘Natural Products News’ Category

USP Herbal Medicines Compendium

Tuesday, May 21st, 2013

United States Pharmacopeial Convention announced Monday the availability of a new compendium that “offers freely available testing standards to help ensure the quality of herbal ingredients used in traditional medicines”

“Biosortia Pharmaceuticals Creating [Anti-Cancer] Drug Discovery Opportunity with Previously Unstudied Microorganisms”

Saturday, May 4th, 2013

Douglas Kinghorn (PI, Ohio State University College of Pharmacy) and colleagues will work closely with Guy Carter (Biosortia Chief Scientific Officer) to discover new, active compounds with activity toward human colon and other cancers from pre-fractionated extracts from microorganism corsortia.

SciFinder Science in the News – Natural Products Chemistry

Monday, April 1st, 2013

The SciFinder Science in the News series has posted three videos (Feb 22 to Mar 21) on YouTube highlighting “ever-evolving and important world of” natural products chemistry.  Featured in the videos are Doug Kinghorn, Gordon Cragg and Roger Schenck.  Part 1 can be viewed at http://www.youtube.com/watch?v=VyxaVbtBZ9Q, Part 2 at http://www.youtube.com/watch?v=dG9Cn_WYexk, and Part 3 at http://www.youtube.com/watch?v=IdwQBpC9fm4.

Bradley Moore receives ACS Arthur C. Cope Scholar Award

Tuesday, March 19th, 2013

Bradley S. Moore (ASP Vice-President) has been named as a 2013 receipient of the American Chemical Society Arthur C. Cope Scholar Award (C&E News, Mar 4, p 60).  The award is bestowed to recognize outstanding achievement in organic chemistry.  Bradley’s award is in recognition of his efforts to understand the biosynthesis of complex marine nature products.  Congratulations!

FDA Approves Crofelemer as First-Ever Oral Botanical Drug

Thursday, January 3rd, 2013

On New Year’s Eve of 2012, the US Food and Drug Administration (FDA) announced its approval of crofelemer (Fulyzaq™, Salix Pharmaceuticals, Ltd., Raleigh, North Carolina) — marking the second time a botanical, and the first time an orally administered botanical, has received drug approval…”